Liquid Biopsy May Identify NSCLC Patients Who Will Benefit from Radiation
A novel liquid biopsy test may determine which patients with NSCLC that has spread beyond the lungs will benefit from high-dose radiation.
Read MorePosted by Andy Lundin | Oct 2, 2023 | Lung Cancer |
A novel liquid biopsy test may determine which patients with NSCLC that has spread beyond the lungs will benefit from high-dose radiation.
Read MorePosted by Andy Lundin | Sep 29, 2023 | Cancer |
Point32Health and GRAIL announced the expansion of their pilot to offer GRAIL’s Galleri multi-cancer early detection screening test.
Read MorePosted by Andy Lundin | Sep 22, 2023 | Diagnostic Technologies |
A study demonstrated clinical utility of Predicine’s MRD liquid biopsy assay in support of Genentech’s Phase 1 Clinical Trial of Divarasib.
Read MorePosted by Chris Wolski | Sep 20, 2023 | Microscopy |
Gestalt’s Mitotic Counting algorithm was trained on over 100,000 individual mitosis and across seven scanner models.
Read MorePosted by Chris Wolski | Sep 19, 2023 | Cancer |
Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to...
Read More